Lyell Immunopharma, Inc. (LYEL) Profit Margin
Lyell Immunopharma, Inc. (LYEL) net profit margin by fiscal period. Analyze profit margins in Excel with MarketXLS.
Profit Margin Data
| Period | Net Profit Margin |
|---|---|
| 2021-12-31 | -2349.47% |
| 2022-12-31 | -216.24% |
| 2023-12-31 | -180486.15% |
| 2024-12-31 | -562285.25% |
| 2025-12-31 | -762355.56% |
How LYEL compares with sector peers
| Symbol | Company | Net profit margin (latest fiscal year) |
|---|---|---|
| BNTC | Benitec Biopharma Inc. | -26082.67% |
| INMB | INmune Bio Inc. | -91800.00% |
| INO | Inovio Pharmaceuticals Inc. | -130000.00% |
| ALT | Altimmune Inc. | -214860.98% |
| ALLO | Allogene Therapeutics Inc. | -1170863.64% |
These are five companies in the same sector as LYEL with a comparable annual net profit margin. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Lyell Immunopharma, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Profit_Margin("LYEL", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | LYEL | $15.53 | +1.17% | 0.10M |
| 3 | ||||
| 4 | ||||
| 5 |